Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Here is the one sector bucking the trend in a weak market; Check out top gainers
Five among the top 10 gainers on the Nifty 500 index are Pharma stocks. They include Pfizer (Up 4.6%), Anthem Biosciences (Up 2.5%), Syngene (Up 2%), Aster DM Healthcare (Up 2%) and Wockhardt (Up 2%).
Pfizer Q4 profit falls despite revenue, EBITDA growth; ₹75 dividend declared
Pfizer reported a decline in fourth-quarter profit despite higher revenue and EBIDTA, while the board recommended a final dividend of ₹75 per share for FY26.
Pfizer Declares Bumper Dividend Of Rs 75/Share Even As Q4 Profit Slides; Check Record Date
Notably, the pharma giant's net profit for the fourth quarter of FY26 has slumped 39.6% year-on-year to Rs 200 crore
Q4FY26 Results Today: Dixon Tech, Tata Power, One MobiKwik, Dr Reddy's Among 100+ Firms To Declare Earnings
Pfizer, Nazara Technologies, Thomas Cook (India) and Torrent Power are among the prominent names that will declare quarterly results on May 12.
Q4 Results LIVE Updates: Dr. Reddy's, Dixon report results today; Indian Hotels, Anant Raj react
Q4 Results LIVE Updates: Its an earnings-heavy day on the Dalal Street today. Nifty 50 stock Dr Reddy's Laboratories is scheduled to report its numbers today. Dixon Tech, Berger Paints, Nazara Tech, INOX India, Cohance Lifesciences, Gopal Snacks, Kalpataru, KPR Mill, Max Financial Services, MobiKwik, MTAR Tech, Novartis, Pfizer, Religare, Keystone Developers, Sagility, Tata Power, Torrent Power, Texmaco Rail, V-Guard Industries, are among the other important results to track today. Watch this space for all the LIVE earnings updates.
Pfizer among 6 stocks showing bullish RSI upswing
Six stocks from the Nifty500 universe were flagged in the RSI Trending Up scan on April 28. The indicator turned positive as RSI crossed above 50 from lower levels, signalling strengthening momentum, improving sentiment, and potential short-term buying opportunities in stocks showing early signs of technical recovery.
Trump administration gears up for new tariffs on select drugmakers
Trump plans 100% tariffs as soon as Thursday on drugmakers lacking low price deals, while firms like Pfizer and Eli Lilly get a three year reprieve under prior agreements
What sets apart MNC pharma companies from their Indian counterparts
Dividend payments by Abbott and Pfizer increased significantly in last two fiscal years even as they lag Indian majors in growth